Stay updated on PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib

Sign up to get notified when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.
Latest website image capture
Clouds background image

Latest updates to the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:53:25.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for the clinical trial involving Olaparib vs. Placebo in patients with advanced ovarian, fallopian tube, or peritoneal cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:43:02.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change includes a detailed explanation of eligibility criteria and examples such as a person's general health condition or prior treatments.
    Difference
    42%
    Check dated 2024-05-22T21:02:53.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:59:18.000Z thumbnail image

Stay in the know with updates to PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib

Enter your email address, and we'll notify you when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.